Our Advisors
IMEG Health® is a new experience in Traditional Chinese Medicine ("TCM"). In addition to our team of doctors, we have engaged a number of like-minded professional advisors who share our vision for TCM.
To elevate the standard of care and practise of TCM, and to support life-long health management with TCM services. In order to realize our vision, IMeG Health® has engaged professional advisors that will guide us in the Clinic’s development.
Our advisors are well-respected in their various fields of expertise, and their involvement is fundamental to the patient experience at IMEG Health®.
(In alphabetical order)
Mr. Peter H.T. Chan
Mr. Peter H.T. Chan is currently the Chief Project Administrator of Cadenza, a five-year HK$380M project initiated by Hong Kong Jockey Club to foster positive image towards older people and improve quality of care/life for Hong Kong elderly. Mr. Chan also has close ties with the local health authorities, and for more than 18 years he has held leadership positions with the Health Authority in Canada. He was the Director of Strategic Initiatives and Special Projects of Richmond Health Services, Vancouver Coastal Health. That role involved championing primary and community health care redesign. He has also served roles as Program Manager of Diagnostics for Pharmacy and Allied Health, Administrator of Minoru Residence, and the Manager of Patient and Family Counseling of The Richmond Hospital. His extensive involvement with local health authorities is the reason he has been engaged by IMEG Health®. Mr. Chan will help us to align ourselves closely with practices of local health authorities.
Mr. Chan is a well-known healthcare expert in Canada, Hong Kong, Macau and China. He has provided consultancies to governments and NGOs on healthy ageing and long-term care, as well as organizational transformation, quality and risk management, and leadership development. In addition, he has contributed to several publications on quality management and long-term care including “Long Term Care in the 21st Century: Perspective From Around the Asia Pacific Rim” by Haworth Press (2002).
He was a member of the Planning Group for the Implementation of Bill 51 – Adult Guardianship Acts, which included the Health Care Consent and Care Facility Admission Acts. Mr. Chan was appointed as a Commissioner for Taking Affidavits for British Columbia, Canada from 1994 – 1998.
Professor C.T. Che
Professor Chun-Tao Che is Norman R. Farnsworth Professor of Pharmacognosy of the Department of Medicinal Chemistry and Pharmacognosy of University of Illinois, Chicago (UIC). He is a global leading expert in enhancement, standardization and quality control of TCM and is actively engaged in the activities in the “WHO Collaborating Center for Traditional Medicine” at UIC as part of their Program for Collaborative Research in the Pharmaceutical Sciences. Professor Che will assist in IMEG Health®’s endeavors into providing quality TCM products.
Professor Che was the Director of the School of Chinese Medicine of The Chinese University of Hong Kong between 2001 to 2010. He was actively engaged in spearheading the Hong Kong government’s commitment to modernization of Traditional Chinese Medicine. He served on many expert panels and advisory boards set up by the Hong Kong Government, Hospital Authority of Hong Kong, as well as the Hong Kong Jockey Club Institute of Chinese Medicine. He also holds concurrent appointments at the Guangzhou University of Traditional Chinese Medicine, the Jinan University and the Hong Kong University of Science and Technology.
Professor Che is an Associate Editor of Pharmaceutical Biology and serves on the editorial boards of international journals such as Journal of Ethnopharmacology, Phytotherapy Research, Acta Pharmaceutica Sinica, Journal of Asian National Products Research, Chinese Journal of Integrated Traditional and Western Medicine, Chinese Pharmaceutical Journal, China Journal of Traditional Chinese Medicine and other journals in Chinese. Professor Che has published extensively in the areas of medicinal plant chemistry, biological effects of Chinese medicinal plants and their chemical ingredients, as well as standardization of TCM.
Professor Niraj Dawar
Professor Niraj Dawar will advise IMEG Health® in the formulation of our marketing strategy to promote the IMEG Health® experience. Professor Dawar is the Barford Professor of Marketing at the Ivey Business School, University of Western Ontario, Canada. He has done extensive research in the areas of brands, market-based competitive advantage and consumer marketing. His publications in these areas have appeared in the Harvard Business Review, Journal of Marketing Research, Journal of Marketing, M.I.T. Sloan Management Review, Journal of International Business Studies, Marketing Letters, and other academic and managerial outlets. His article entitled “Beyond Better Products”, which was co-authored with Prof. Mark Vandenbosch, appeared in the M.I.T. Sloan Management Review, and was awarded the ‘Best Article’. Additionally, he is the author of a number of award-winning case studies on brand and competitive strategy in global markets, and an active contributor to the business press and international conferences on business and marketing issues.
Professor Dawar has worked extensively with the senior management teams of companies including Algorithmics Financial Software, BMW (AG), Cadbury-Schweppes (Global), Debeers (South Africa), HSBC (Asia), Microsoft (C.E.E.), Sud Chemie (Mexico), S. C. Johnson (Europe), KPMG (Asia), J. Walter Thompson (International), the McCain group (Worldwide), Telus (Canada), and Sun Life Financial.
Previously, he was on the INSEAD faculty in France, and a Visiting Professor at INSEAD Singapore. In 2000, he was Visiting Research Professor at the University of Michigan Business School. In 1994, and again in 1995, he was a Visiting Scholar at the Hong Kong University of Science and Technology.
Dr. Warren Fischer
Doctor of Traditional Chinese Medicine (Dr.TCM)
Registered Acupuncturist (R.Ac)
Dr. Warren Fischer is IMEG Health®’s Clinical Advisor. He is the Academic Dean and Chief Lecturer of the Academy of Classical Oriental Sciences in Nelson B.C. Dr. Fischer holds a Bachelor of Science (Biochemistry, honours) Degree from McGill University, as well as a Degree in Traditional Chinese Medicine from Beijing University of Traditional Chinese Medicine and Pharmacology. In Beijing, he was the only foreign student in a class of forty native Chinese, and he has the distinction of being the first Canadian ever to obtain his Degree from the standard five-year program of traditional Chinese medicine. Dr. Fischer reads, writes, and is fully fluent in Mandarin Chinese.
After his return to Canada, Dr. Fischer’s TCM practice grew quickly, fuelled by the testimonies of those who had been helped. He felt compelled to ensure that the medicine was competently practised and accurately represented to the public. His desire was to grow TCM in the West into the strong and effective profession that it is in China. It was this passion for the medicine that led him to create the Academy of Classical Oriental Sciences (ACOS) in 1996. In fact, because his philosophy regarding the practise of TCM so closely parallels the philosophy of IMEG Health®, Dr. Fischer has been engaged to serve as our Clinical Advisor.
Dr. Fischer’s advocacy for TCM in the West extends beyond IMEG Health® and ACOS. In 1999, he was appointed by the British Columbia Minister of Health as a member of the inaugural Board of the College of Traditional Medicine Practitioners and Acupuncturists of British Columbia (CTCMA). During his three years on the Board, the membership was registered; the first examinations sat; and, the bylaws of the College drafted and approved. British Columbia became the first jurisdiction in North America to license the entire profession of TCM. Dr. Fischer has recently been appointed to the new Expert Committee for the Development of a Competency Profile for the Practice of Acupuncture, which will develop national entry-level competencies for acupuncture across Canada.
Professor P.C. Leung
Professor P. C. Leung has been engaged to advise IMEG Health® in areas of clinical research. He is currently the co-Director of the Institute of Chinese Medicine (ICM), and the Chairman of the Management Committee of the ICM at the Chinese University of Hong Kong (CUHK). In his capacity as the Chairman of the Management Committee, Professor Leung has put enormous efforts toward the modernization of traditional Chinese medicine. He is the Director of the Clinical Trials Section of ICM and has adopted the Efficacy Driven Approach in Clinical Trials. Currently, there are more than 40 clinical trials/ research projects being conducted at the ICM, and an extensive network has been developed internationally. A particularly noteworthy collaboration involved researchers from Harvard University, Keio University, Beijing University and CUHK working together toward advancing the science of traditional Chinese Medicine. Currently, he is involved in a collaborative effort with Sloan Kettering Cancer Institute of New York, U.S.A. that is focusing on the use of anticancer herbs.
Trained as an orthopeadic surgeon, Professor Leung’s research areas include Orthopaedics, Osteoporosis, Microsurgery, Health, Traditional Chinese Medicine and General Education. Professor Leung has been appointed as editor of 5 International Journals since 1982, and he is the author of over 300 scientific manuscripts in journals. He has also authored 17 books, including “A Comprehensive Guide to Chinese Medicine”, “Limb Salvage for Diabetic Ulceration with Traditional Chinese Techniques”, “Treatment of Low Back Pain with Acupuncture”, and he is currently working on a book titled “A Scientist View on Traditional Chinese Medicine”.
Milton K. Wong
LLD, CM, OBC
Milton Wong is known as a successful entrepreneur and a great philanthropist. He founded M. K. Wong & Associates Ltd., an investment firm, which was then acquired by Hong Kong Shanghai Banking Corporation (HSBC). When Milton Wong was not serving as the chairman of HSBC Asset Management (Canada) Ltd., he would be involved in the community. He is one of the founding patrons of The Laurier Institute, past director of Canada-U.S. Fulbright Program, member of the Canadiana Fund, board director of the Pierre Elliott Trudeau Foundation, and board member of International Institute for Sustainable Development. He is a key fund-raiser for organizations such as YMCA, Red Cross, Salvation Army and Science World, he was the organizer of the first Canadian International Dragon Boat Festival, and he was also the co-chair of the BC Cancer Foundation Millennium Campaign. For his outstanding achievement, dedication to the community and service to Canada, Milton Wong has been awarded Order of Canada in 1997, Order of British Columbia in 2003 and Vancouver Civic Merit in 1995. His knowledge and expertise in finance and business is invaluable to IMEG Health®.
Milton Wong received his Bachelor degree from University of British Columbia (UBC) in 1963 and his honorary Doctorate of Law degree from Simon Fraser University (SFU) in 1998. For his outstanding service as SFU chancellor from 1999 to 2005, SFU bestowed him the title chancellor emeritus.
Professor Paul M. Vanhoutte
Professor Paul M. Vanhoutte is the Head of Pharmacology & Pharmacy, and the Director of Bio-pharmaceutical Development Centre of the University of Hong Kong, and his role with IMEG Health® will be to facilitate research collaboration in the development of herbal medicines. A native of Belgium, Professor Vanhoutte has a distinguished career both in academia and the industry. His academic career started at the University of Gent, followed by the University of Antwerp, the Mayo Clinic, and Baylor College of Medicine (Houston Tx, U.S.A.). He has also attended universities in Europe, U.S.A., Asia and Africa. Professor Vanhoutte received the Doctor Honoris Causa degree of the University of Gent in 2001, from the Universities of Antwerp, Montreal and Zurich in 2003, from the Royal Melbourne Institute of Technology in 2005, and from the University Louis Pasteur in Strasbourg in 2006.
From 1992 to 2002, Professor Vanhoutte was Vice-President R&D, and Director of Discovery Research at the Institut de Recherches Internationales Servier, in Courbevoie (Paris, France). From 1989 to 2007, Professor Vanhoutte was Editor-in-Chief of the Journal of Cardiovascular Pharmacology in addition to being a member of the Editorial Board of many scientific journals. His major scientific contribution has been to appreciate and analyse the importance of endothelial cells in the control of the underlying vascular smooth muscle in health and disease, and to highlight the complexity of that regulation. Professor Vanhoutte is a Highly Cited Researcher (ISI) in three categories: Biology & Chemistry, Pharmacology, and Clinical Medicine.
Dr. Michael Chung
Dr. Michael Chung holds a Master’s and Ph.D. Degree of TCM (China), as well as a Bachelor Degree in Pharmacy (Taiwan), enabling him to have a unique integrated view on clinical treatment.
Dr. Chung has practiced TCM for more than 20 years, with special expertise in the area of diabetes, infertility and sports injuries. He is currently a research associate for BC Cancer Agency and a Board member of CICMR (Canadian Institute of Chinese Medicine Research).
Dr. Chung has been a registrant of the College of Traditional Chinese Medicine Practitioners and Acupuncturists of B.C. (CTCMA) since 2000. He is fluently bilingual and has devoted himself as a TCM speaker and translator at many medical and public education events.